Beam Therapeutics Inc. (BEAM) vs Privia Health Group, Inc. (PRVA)
A side-by-side comparison of Beam Therapeutics Inc. and Privia Health Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BEAM
Beam Therapeutics Inc.
$25.12HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
PRVA
Privia Health Group, Inc.
$20.47HealthcareDelayed quote: Oct 6, 2026, 3:15 PM EDT
Total return — BEAM vs PRVA
growth of $100 · dividends reinvested · last 5yBEAM -68.7% (-20.7%/yr)PRVA -11.1% (-2.3%/yr)PRVA compounded faster over this window
BEAM PRVA
BEAM vs PRVA: by the numbers
- •BEAM is the larger company ($2.58B vs $2.58B market cap).
- •PRVA is profitable (1.19% net margin) while BEAM runs a net loss (-54.75%).
- •BEAM grew revenue faster over the past five years (479.04% vs 22.35% CAGR).
Metrics side by side
Valuation
| Metric | BEAM | PRVA |
|---|---|---|
| P/E ratio | N/A | 94.37 |
| Forward P/E | N/A | 79.48 |
| P/S ratio | 16.56 | 1.09 |
| P/B ratio | 2.42 | 0.00 |
Profitability
| Metric | BEAM | PRVA |
|---|---|---|
| Gross margin | 84.05% | 7.61% |
| Operating margin | -274.57% | 1.90% |
| Net margin | -54.75% | 1.19% |
| ROE | -8.00% | 0.00% |
| ROIC | -28.96% | 0.00% |
Growth (annualized)
| Metric | BEAM | PRVA |
|---|---|---|
| Revenue CAGR (5Y) | 479.04% | 22.35% |
| EPS CAGR (5Y) | N/A | -8.73% |
| Total return CAGR (5Y) | -21.41% | -1.30% |
Frequently asked
- Which has grown faster, BEAM or PRVA?
- Over the past five years, BEAM grew revenue faster — BEAM at a 479.04% CAGR versus PRVA at 22.35%.
- Is BEAM or PRVA more profitable?
- PRVA runs the higher net margin — BEAM at -54.75% versus PRVA at 1.19%.
- How have BEAM and PRVA total returns compared?
- Over the past 5 years, BEAM delivered -21.41% and PRVA delivered -1.30% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Privia Health P/E ratioBeam Therapeutics ROEPrivia Health ROEBeam Therapeutics operating marginPrivia Health operating marginBeam Therapeutics revenue growthPrivia Health revenue growthBeam Therapeutics free cash flowPrivia Health free cash flow
Beam Therapeutics & Privia Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.